| Literature DB >> 31193148 |
Yoshitaka Nakanishi1, Takamitsu Okada1, Naohide Takeuchi1, Naoya Kozono1, Takahiro Senju1, Koichi Nakayama2, Yasuharu Nakashima1.
Abstract
INTRODUCTION: Tendon tissue engineering requires scaffold-free techniques for safe and long-term clinical applications and to explore alternative cell sources to tenocytes. Therefore, we histologically assessed tendon formation in a scaffold-free Bio-three-dimensional (3D) construct developed from normal human dermal fibroblasts (NHDFs) using our Bio-3D printer system under tensile culture in vitro.Entities:
Keywords: 3D, three-dimensional; ECM, extracellular matrix; ESCs, embryonic stem cells; H&E, hematoxylin and eosin; HDF, human dermal fibroblast; Human dermal fibroblast; In vitro study; MCSs, multicellular spheroids; Multicellular spheroid; NHDFs, normal HDFs; Scaffold-free; TDSCs, tendon-derived stem cells; TGF, transforming growth factor; Tendon formation; Tensile culture
Year: 2019 PMID: 31193148 PMCID: PMC6517794 DOI: 10.1016/j.reth.2019.02.002
Source DB: PubMed Journal: Regen Ther ISSN: 2352-3204 Impact factor: 3.419
Fig. 1Materials for and process of manufacturing three-dimensional (3D) Bio-printed ring-like tissue and human neo-tendon tissue under static tensile loading. (a) Image of multicellular spheroid (MCS) produced from normal human dermal fibroblasts (NHDFs). Scale bar = 100 μm. (b) Predesigned 3D ring-like structure. Green spheres represent MCSs. (c) Image of the Bio-3D printer (Regenova). (d) Image of the Kenzan needle-array after skewering MCSs. (e) Image of ring-like tissue after removal from the needle array. (f) Image of the in-house uniaxial tensile device. (g) Image of the tensile device without tissues (upper) and with tissues (lower) at the initial strength point. A: main, B: middle, and C: spring-anchor base. Image of ring-like tissues in the (h) tension-free and (i) tension-loaded groups.
Modified tendon-maturing score.
| 1 | 2 | 3 | 4 | |
|---|---|---|---|---|
| Cellularity | Marked | Moderate | Mild | Minimal |
| Proportion of cells resembling tenocytes | <25% | 25–50% | 50–75% | >75% |
| Proportion of cells oriented in parallel | <25% | 25–50% | 50–75% | >75% |
| Proportion of fibers of large diameter characteristic of mature tendon fibers | <25% | 25–50% | 50–75% | >75% |
| Proportion of fibers oriented in parallel | <25% | 25–50% | 50–75% | >75% |
Fig. 2Histological analysis of the tension-free group. Images showing changes in construct shape with prolonged culture (a) and gross view at weeks 4 (b) and 8 (c). Photomicrographs showing hematoxylin and eosin (H&E) staining (d and g) and Masson's trichrome staining (e, f, h, and i) of in vitro-cultured tissue without tension-loading at weeks 4 (b and d–f) and 8 (c and g–i). Scale bars = 2 mm (a), 100 μm (d, e, h, and i), and 50 μm (f and i).
Fig. 3Histological analysis of the tension-loaded group. Images showing changes in construct shape with prolonged culture (a) and gross view at weeks 4 (b) and 8 (c). Photomicrographs showing hematoxylin and eosin (H&E) staining (d and g) and Masson's trichrome staining (e, f, h, and i) of in vitro-cultured tissue with tension loading at weeks 4 (b and d–f) and 8 (c and g–i). Scale bars = 2 mm (a), 100 μm (d, e, g, and h), 50 μm (f) and 20 μm (i).
Histological analysis.
| Tension-free group | Tension-loaded group | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | |
| Week 4 evaluation, | ||||||||
| Cellularity | 4 | 0 | 0 | 0 | 1 | 3 | 0 | 0 |
| Fibrocytes | 4 | 0 | 0 | 0 | 4 | 0 | 0 | 0 |
| Fiber diameter | 4 | 0 | 0 | 0 | 1 | 3 | 0 | 0 |
| Cells, parallel | 4 | 0 | 0 | 0 | 3 | 1 | 0 | 0 |
| Fibers, parallel | 3 | 1 | 0 | 0 | 3 | 1 | 0 | 0 |
| Week 8 evaluation, | ||||||||
| Cellularity | 1 | 3 | 0 | 0 | 0 | 4 | 0 | 0 |
| Fibrocytes | 4 | 0 | 0 | 0 | 0 | 3 | 1 | 0 |
| Fiber diameter | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 2 |
| Cells, parallel | 4 | 0 | 0 | 0 | 0 | 3 | 1 | 0 |
| Fibers, parallel | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 4 |
Fig. 4Histological scoring. Histological scoring of tension-free and tension-loaded groups at weeks 4 and 8. A perfect score on this scale is 20 points. *P < 0.0001; **P < 0.0001; and ***P < 0.0001 (n = 4).
Fig. 5Immunohistochemical analysis of tenascin. Photomicrographs of immunohistochemical staining for tenascin C (a–d) and the magnification (f–i). (e and j) Negative controls for immunostaining. Scale bars = 50 μm (a–e) and 20 μm (f–j).
Fig. 6Immunohistochemical analysis of scleraxis. Photomicrographs of immunohistochemical staining for scleraxis (a–d) and the magnification (f–i). (e and j) Negative controls for immunostaining. Scale bars = 50 μm (a–e) and 10 μm (f–j).